D-fraction is a proteoglycan extract from the fruiting body of Maitake mushroom through separation and refining. The ratio of polysaccharide to protein is 7:3, and the average molecular weight is 1 million. Part of the polysaccharide is a beta – (1-3) side chains of beta glucan (1-6) and has a beta – (1-6) side chains of beta glucan (1-3). The first-line biochemotherapeutic anticancer drugs used clinically in Japan, the United States, Europe and other countries are highly effective oral immunoactivators with high-potency biochemotherapeutic agents with high-potency immunofocused killing effect on cancer cells.
Efficacy of Maitake Extract D-Fraction series on patients at different periods of time
1. Newly diagnosed, but not yet undergoing surgery or chemoradiotherapy: it can activate the immune system, which is expected to inhibit metastasis while killing cancer cells, stabilize the disease, and gain favorable time for follow-up treatment such as surgery;
2. During radiotherapy and chemotherapy after surgery: it can enhance immunity, improve physique, and minimize the toxic side effects of radiotherapy and chemotherapy; At the same time, it is expected to have synergistic effect with some traditional anti-cancer drugs to enhance the effect of chemotherapy.
3, after surgery, radiotherapy and chemotherapy: can effectively maintain the normal immune function of the human body, enhance physical fitness, prevent possible metastasis and recurrence;
4, terminal critical patients: can reduce pain, improve appetite, slow the development of the disease, prolong survival time, improve the quality of life;
Post time: Nov-11-2022
